𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor-specific CD4+T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells

✍ Scribed by Ilseyar Akhmetzyanova, Gennadiy Zelinskyy…

Book ID
120770994
Publisher
Springer-Verlag
Year
2012
Tongue
English
Weight
848 KB
Volume
62
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Naive CD4+ T cells confer idiotype-speci
Naive CD4+ T cells confer idiotype-specific tumor resistance in the absence of antibodies
✍ Bjarne Bogen; Ludvig Munthe; Anders Sollien; Peter Hofgaard; Hilde Omholt; Frede 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

MOPC315 plasmacytoma [9], was employed. Upon processing, the U3'' L chain yields a CDR3-fragment comprising residues 91-101. This Id-peptide is presented on the I-Ed class 11 molecule. Amino acids Phe94, Arg9', of the

CD4+ T cell-mediated HER-2/neu-specific
CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells
✍ Jan Alvar Lindencrona; Susanne Preiss; Thomas Kammertoens; Thomas Schüler; Marie 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB

## Abstract HER‐2/neu (HER‐2) is a cell surface proto‐oncogene that is often overexpressed in carcinomas. Passive administration of anti‐HER‐2 antibodies in breast cancer patients has achieved promising results, but less is known about the role of antibodies in active immunization. We asked whether